VHCP Management II as of Dec. 31, 2018
Portfolio Holdings for VHCP Management II
VHCP Management II holds 19 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 18.1 | $42M | 1.1M | 36.98 | |
| Ascendis Pharma A S (ASND) | 13.6 | $32M | 504k | 62.65 | |
| Obseva Sa | 12.2 | $29M | 2.3M | 12.66 | |
| BioCryst Pharmaceuticals (BCRX) | 11.3 | $26M | 3.2M | 8.07 | |
| Tricida | 9.7 | $23M | 963k | 23.58 | |
| Kiniksa Pharmaceuticals (KNSA) | 7.7 | $18M | 639k | 28.09 | |
| Kalvista Pharmaceuticals (KALV) | 6.4 | $15M | 759k | 19.75 | |
| Zogenix | 5.7 | $13M | 362k | 36.46 | |
| Ra Pharmaceuticals | 4.9 | $12M | 633k | 18.20 | |
| Dbv Technologies S A (DBVT) | 1.7 | $3.9M | 463k | 8.41 | |
| Bellerophon Therapeutics | 1.4 | $3.3M | 4.1M | 0.80 | |
| Kadmon Hldgs | 1.3 | $2.9M | 1.4M | 2.08 | |
| Spero Therapeutics (SPRO) | 1.2 | $2.9M | 474k | 6.15 | |
| Constellation Pharmceticls I | 1.2 | $2.9M | 727k | 4.01 | |
| Orchard Therapeutics Plc ads | 1.0 | $2.3M | 149k | 15.73 | |
| Marinus Pharmaceuticals | 0.9 | $2.1M | 744k | 2.87 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $1.7M | 250k | 6.73 | |
| Proteostasis Therapeutics In | 0.7 | $1.6M | 501k | 3.24 | |
| Gemphire Therapeutics | 0.2 | $416k | 514k | 0.81 |
